Faron Pharmaceuticals Oy Net Asset Quality Index
Faron Pharmaceuticals Oy net asset quality index. Faron Pharmaceuticals Oy (FARN) has a Net Asset Quality Index of -100.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX16.20 Million minus total liabilities of GBX32.45 Million yields net assets of GBX-16.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. See FARN net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Faron Pharmaceuticals Oy (2012–2024)
Net asset quality index of Faron Pharmaceuticals Oy from 2012 to 2024. This chart shows how Faron Pharmaceuticals Oy's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the index stands at -100.3%, representing net assets of GBX-16.25 Million against total assets of GBX16.20 Million GBX. Check Faron Pharmaceuticals Oy (FARN) strategic investment index to assess the company's strategic physical and investment asset allocation.
Faron Pharmaceuticals Oy Net Asset Quality Index by Year (2012–2024)
Faron Pharmaceuticals Oy net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Faron Pharmaceuticals Oy from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see FARN stock market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -78.0% | GBX-9.76 Million | GBX12.52 Million | GBX22.28 Million | ▲ +70.4 pp |
| 2023 | -148.3% | GBX-15.16 Million | GBX10.22 Million | GBX25.38 Million | ▼ -46.5 pp |
| 2022 | -101.8% | GBX-11.48 Million | GBX11.27 Million | GBX22.75 Million | ▼ -124.0 pp |
| 2021 | 22.1% | GBX2.92 Million | GBX13.18 Million | GBX10.26 Million | ▲ +44.2 pp |
| 2020 | -22.1% | GBX-1.85 Million | GBX8.37 Million | GBX10.22 Million | ▼ -37.9 pp |
| 2019 | 15.8% | GBX1.61 Million | GBX10.21 Million | GBX8.60 Million | ▲ +11.2 pp |
| 2018 | 4.6% | GBX369.00K | GBX8.00 Million | GBX7.63 Million | ▼ -27.2 pp |
| 2017 | 31.9% | GBX4.74 Million | GBX14.89 Million | GBX10.14 Million | ▼ -31.1 pp |
| 2016 | 63.0% | GBX10.88 Million | GBX17.29 Million | GBX6.40 Million | ▼ -12.5 pp |
| 2015 | 75.4% | GBX11.18 Million | GBX14.82 Million | GBX3.64 Million | ▲ +130.3 pp |
| 2014 | -54.9% | GBX-1.19 Million | GBX2.17 Million | GBX3.35 Million | ▼ -12.5 pp |
| 2013 | -42.4% | GBX-949.00K | GBX2.24 Million | GBX3.19 Million | ▲ +0.8 pp |
| 2012 | -43.2% | GBX-837.00K | GBX1.94 Million | GBX2.77 Million | — |